Banca de DEFESA: CLÁUDIA DAMASCENO PEREIRA CALDEIRA

EVALUATION OF THE IMPACT OF THE RESOLUTION OF THE SUS OMBUDSMAN'S OFFICE IN THE JUDICIALIZATION OF MEDICINES FROM 2015 TO 2019 Brasilia

KEYWORDS: judicialization, SUS Ombudsman, resolution rate.

The ombudsmen of the Unified Health System are an important tool in the field of democratic and participatory management, for guaranteeing the right to health, provided for in the 1988 Federal Constitution. difficulties in accessing health services. Thus, given the inability of the State to meet the demands of the population, there has been an exponential growth in lawsuits, the main cause of which is medication. In this sense, the aim of this research is to evaluate the impact of the resolution of the demands registered by the Ombudsman of the SUS in the judicialization of medication requests, from 2015 to 2019. For this purpose, an ecological, longitudinal research was carried out, with analysis of Quali-quantitative data, containing data and information from a secondary public source, based on time series, through data obtained through Excel spreadsheets, extracted from the OuvidorSUS System, by technicians from the SUS Ombudsman and the Bigdata Panel, referring to the years 2015 to 2019, using statistical analysis with Eviews software. In addition, data from “Justice in Numbers”, from the National Council of Justice, through the National Database of the Judiciary Power (DATAJUD), from 2015 to 2019 were used. The number of manifestations about medicines was increasing every year, especially when Law nº 13.460/2017 was created (historical landmark of the ombudsman), according to the graphs previously informed in the management reports. On the other hand, according to a report by “Justice in Numbers” (2021), since 2017 the number of new lawsuits on medicines has fallen, rising again in 2020. after the statistical analysis, it was observed that the effect of the resolution rates of the SUS ombudsman on the total number of new cases in the justice system was positive. Furthermore, there was an impact of Law nº 13,460/2017 on the resolution rate of the SUS Ombudsman, with a shorter deadline for closing demands for medication requests after the regulatory framework.